Berberine vs metformin
People ask this because both lower blood glucose and because berberine is marketed as the herbal alternative. The direct comparison we could read is one pilot study from 2008. It is not a license to stop a prescription.
| Berberine | Metformin | |
|---|---|---|
| What it is | A plant alkaloid sold as a supplement | A prescription diabetes drug |
| Head-to-head we read | One 2008 pilot. Authors said the glucose effect looked similar. The abstract prints the berberine group's numbers, not metformin's. | |
| Larger berberine reviews | Glucose meta-analyses against mixed controls, not a pure metformin showdown | Not re-reviewed here. This page does not recap metformin's heart-outcome trials. |
The only head-to-head in the abstracts we read
Yin 2008 (PMID 18442638, doi:10.1016/j.metabol.2008.01.013) is a pilot. In study A, 36 adults with newly diagnosed type 2 diabetes were randomized to berberine or metformin, 0.5 g three times a day, for 3 months. The abstract says the hypoglycemic effect of berberine was similar to metformin. It then gives the berberine group's changes: HbA1c from 9.5% ± 0.5% to 7.5% ± 0.4%, fasting glucose from 10.6 ± 0.9 mmol/L to 6.9 ± 0.5 mmol/L, post-meal glucose from 19.8 ± 1.7 to 11.1 ± 0.9 mmol/L, triglycerides from 1.13 ± 0.13 to 0.89 ± 0.03 mmol/L. It does not print the same figures for the metformin group. "Similar" is the authors' summary, not a table you can check from the abstract.
Study B was not a comparison. Forty-eight adults with poorly controlled type 2 diabetes had berberine added for 3 months. HbA1c fell from 8.1% ± 0.2% to 7.3% ± 0.3%. Fasting insulin fell 28.1% and HOMA-IR 44.7%. Across the trial, 20 people (34.5%) had transient gastrointestinal effects. The authors say they did not see functional liver or kidney damage.
The meta-analyses are not a metformin duel
Xie 2022 (PMID 36467075) is 37 studies and 3,048 people with type 2 diabetes: fasting glucose −0.82 mmol/L, HbA1c −0.63 percentage points, 2-hour glucose −1.16 mmol/L. Controls include usual care and other drugs, not metformin alone in every trial.
Liang 2019 (PMID 30393248) is 28 studies and 2,313 people: fasting glucose −0.54 mmol/L, post-meal glucose −0.94 mmol/L. The HbA1c line in that abstract is printed as −0.54 mmol/L, which is an odd unit for HbA1c. In subgroups, the effect looked unremarkable after 90 days, above 2 g/day, or over age 60. Berberine combined with a hypoglycemic drug beat either alone.
Neither review is a reason to call berberine a metformin replacement. Metformin's long outcome trials are a different literature, and this page does not pretend to summarize them. The marketing comparison with Ozempic is a third, separate claim, answered in Do GLP-1 supplements work?
Sources
- Yin J, Xing H, Ye J. Berberine in type 2 diabetes. Metabolism. 2008. PMID 18442638. DOI 10.1016/j.metabol.2008.01.013.
- Xie W, et al. Berberine glucose meta-analysis. PMID 36467075.
- Liang Y, et al. Berberine glucose meta-analysis. PMID 30393248.